Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03818919 · ClinicalTrials.gov registry record · Phase 2

Nonopioid Analgesia After Rotator Cuff Repair

A Phase 2 study of Rotator Cuff Tear, sponsored by Henry Ford Health System.

Completed
Registry status
Phase 2
Development phase
70
Enrollment target
1
Study location

NCT03818919 is a Phase 2 study of Rotator Cuff Tear that has completed, run by Henry Ford Health System. The registered enrollment target is 70 participants, below the 87-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03818919, a Phase 2 study of Rotator Cuff Tear, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
Phase 2
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Ketorolac
  • DRUG Celecoxib
  • DRUG Gabapentin
  • DRUG Diazepam

Study Locations (1)

Michigan

  • Health Ford Health System - Detroit

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2019-01-22
Est. Completion 2020-12-31
Phase Phase 2

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT03818919

The ClinicalTrials.gov registry entry for NCT03818919 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (20% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.

NCT03818919 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03818919 about?

NCT03818919 is a clinical study titled "Nonopioid Analgesia After Rotator Cuff Repair". This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given sta...

What is the current status of trial NCT03818919?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2019-01-22. Estimated completion is 2020-12-31.

What conditions does trial NCT03818919 study?

This clinical trial studies the following conditions: Rotator Cuff Tear.

What interventions are being tested in trial NCT03818919?

The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Celecoxib (DRUG), Gabapentin (DRUG), Diazepam (DRUG).

Who is sponsoring clinical trial NCT03818919?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03818919 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.